Stay updated on SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.

Latest updates to the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a comprehensive Locations section listing study sites across US states and Canadian provinces. Removed outdated location listings and the HHS Vulnerability Disclosure link; updated revision to v3.3.3.SummaryDifference2%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedFooter revision label updated from Revision: v3.2.0 to Revision: v3.3.2.SummaryDifference0.0%

- Check52 days agoChange DetectedThe government funding status notice was removed from the page; previously, the notice warned that information may not be up to date due to funding lapses and directed users to cc.nih.gov and opm.gov for operating status.SummaryDifference0.1%

- Check66 days agoChange DetectedNo significant additions or deletions were detected in the study details page; changes appear to be routine data updates or UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedReplace Sage Therapeutics with Supernus Pharmaceuticals, Inc. and update date references to 2025-10-01 and 2025-10-14, with an “Last Update Posted (Estimated)” marker. Interpreted as a branding/ownership or documentation update rather than substantive content changes.SummaryDifference1%

- Check95 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

Stay in the know with updates to SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.